Table 1.
Analysis of BRAFV600 (B-type Raf kinase) mutation in function of clinico-pathological characteristics.
| Clinical Characteristics | BRAF Positive (n = 42) | BRAF Negative (n = 33) | p Value |
|---|---|---|---|
| Age (mean ± SD) | 38.64 ± 16 | 38.91 ± 14.7 | 0.996 |
| Size (cm) (mean ± SD) | 2.02 ± 1.3 | 2.1 ± 1.3 | 0.523 |
| Histology FVPTC * | 7.1% | 39.3% | 0.001 |
| Gender male | 19% | 21.2% | 0.816 |
| Multifocality | 42.8% | 33.3% | 0.401 |
| Presence of invasion | 48.7% | 25% | 0.048 |
| Presence of lymph node metastasis | 75% | 35.4% | 0.001 |
* Follicular variant papillary thyroid cancer.